🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hari Menon

University of Wisconsin–Madison

ORCID: 0000-0001-5684-1405

Also affiliated with St.John's Medical College Hospital

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial”.

Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001001
N/A
4.9DataRank · unranked
289 citations

Hari Menon, Dawei Chen, Vivek Verma, Chad Tang, Mehmet Altan +12 more

Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000492
N/A
2.9DataRank · unranked
108 citations

Hari Menon, Vivek Verma, Chunxiao Guo, Rishab Ramapriyan, Hampartsoum B. Barsoumian +6 more

Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000537
N/A
0.808DataRank · unranked
217 citations

Rishab Ramapriyan, Ahmed Younes, Mauricio S. Caetano, Hari Menon, Nathan Comeaux +16 more

Bone morphogenetic protein 7 promotes resistance to immunotherapy

Nature Communications(2020)10.1038/s41467-020-18617-z
N/A
0.614DataRank · unranked
59 citations

Fatemeh Masrorpour, Cristina Ivan, Jie Zhang, Ahmed Younes, Yue Lu +13 more

SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti–PD-1–Resistant Model of Non–Small Cell Lung Cancer

Cancer Immunology Research(2020)10.1158/2326-6066.cir-19-0744
N/A
0DataRank · unranked
125 citations

Hampartsoum B. Barsoumian, Liangpeng Yang, Ahmed Younes, Vivek Verma, Yun Hu +9 more

Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.08.022
N/A
0DataRank · unranked
98 citations

John V. Heymach, Chunxiao Guo, Hari Menon, Katherine Klein, Taylor R. Cushman +19 more

Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity

Translational Oncology(2020)10.1016/j.tranon.2020.100983
N/A
0DataRank · unranked
29 citations

Hampartsoum B. Barsoumian, Duygu Sezen, Vivek Verma, Roshal R. Patel, Mark Wasley +12 more